BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1615 related articles for article (PubMed ID: 34976920)

  • 21. Development, Status Quo, and Challenges to China's Health Informatization During COVID-19: Evaluation and Recommendations.
    Huang M; Wang J; Nicholas S; Maitland E; Guo Z
    J Med Internet Res; 2021 Jun; 23(6):e27345. PubMed ID: 34061761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Environmental management strategy in response to COVID-19 in China: Based on text mining of government open information.
    Kang A; Ren L; Hua C; Song H; Dong M; Fang Z; Zhu M
    Sci Total Environ; 2021 May; 769():145158. PubMed ID: 33485207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requestioning the Indonesia Government's Public Policy Response to the COVID-19 Pandemic: Black Box Analysis for the Period of January-July 2020.
    Ayuningtyas D; Haq HU; Utami RRM; Susilia S
    Front Public Health; 2021; 9():612994. PubMed ID: 34041213
    [No Abstract]   [Full Text] [Related]  

  • 24. From SARS to the Omicron variant of COVID-19: China's policy adjustments and changes to prevent and control infectious diseases.
    Luo M; Liu Q; Wang J; Gong Z
    Biosci Trends; 2022 Jan; 15(6):418-423. PubMed ID: 34924490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of China's public health system response to COVID-19.
    Zhang P; Gao J
    J Glob Health; 2021 Jan; 11():05004. PubMed ID: 33643637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparative politics of COVID-19: The need to understand government responses.
    Greer SL; King EJ; da Fonseca EM; Peralta-Santos A
    Glob Public Health; 2020 Sep; 15(9):1413-1416. PubMed ID: 32564670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 Lessons and Post-pandemic Recovery: A Case of Latvia.
    Šteinbuka I; Austers A; Barānovs O; Malnačs N
    Front Public Health; 2022; 10():866639. PubMed ID: 35462839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humiliating Whistle-Blowers: Li Wenliang, the Response to Covid-19, and the Call for a Decent Society.
    Nie JB; Elliott C
    J Bioeth Inq; 2020 Dec; 17(4):543-547. PubMed ID: 32840823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Digital Economy on the Provision Efficiency for Public Health Services: Empirical Study of 31 Provinces in China.
    Lyu Y; Peng Y; Liu H; Hwang JJ
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expanding public health in China: an empirical analysis of healthcare inputs and outputs.
    Deng F; Lv JH; Wang HL; Gao JM; Zhou ZL
    Public Health; 2017 Jan; 142():73-84. PubMed ID: 28057203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Authoritarian Regime Legitimacy and Health Care Provision: Survey Evidence from Contemporary China.
    Duckett J; Munro N
    J Health Polit Policy Law; 2022 Jun; 47(3):375-409. PubMed ID: 34847220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Strengthening Mechanism of the Relationship between Social Work and Public Health under COVID-19 in China.
    Zheng G; Zhang X; Wang Y; Ma M
    Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The challenge of healthcare big data to China's commercial health insurance industry: evaluation and recommendations.
    Wu J; Qiao J; Nicholas S; Liu Y; Maitland E
    BMC Health Serv Res; 2022 Sep; 22(1):1189. PubMed ID: 36138390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pandemic backsliding: Violations of democratic standards during Covid-19.
    Edgell AB; Lachapelle J; Lührmann A; Maerz SF
    Soc Sci Med; 2021 Sep; 285():114244. PubMed ID: 34399291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. China's local governments are combating COVID-19 with unprecedented responses - from a Wenzhou governance perspective.
    Gong F; Xiong Y; Xiao J; Lin L; Liu X; Wang D; Li X
    Front Med; 2020 Apr; 14(2):220-224. PubMed ID: 32166600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coevolution of COVID-19 research and China's policies.
    Cheng X; Tang L; Zhou M; Wang G
    Health Res Policy Syst; 2021 Sep; 19(1):121. PubMed ID: 34488797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International institutions and China's health policy.
    Huang Y
    J Health Polit Policy Law; 2015 Feb; 40(1):41-71. PubMed ID: 25480846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. China's COVID-19 Control Strategy and Its Impact on the Global Pandemic.
    Ding D; Zhang R
    Front Public Health; 2022; 10():857003. PubMed ID: 35359767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. China's model to combat the COVID-19 epidemic: a public health emergency governance approach.
    Ning Y; Ren R; Nkengurutse G
    Glob Health Res Policy; 2020; 5():34. PubMed ID: 32685691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic evolution of policy mix in response to COVID-19: Practice from China.
    Du L; Lu W
    PLoS One; 2023; 18(9):e0291633. PubMed ID: 37768975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 81.